We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$51.7M
2
MSFT icon
Microsoft
MSFT
+$40.6M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$20.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.9M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$31.8M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$27.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$21.9M
4
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$18.4M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOAH
3926
Noah Holdings
NOAH
$594M
– –
-1,187
Closed -$56K
NOG icon
3927
Northern Oil and Gas
NOG
$2.21B
$0 ﹤0.01%
+10
New +$225
NTIC icon
3928
Northern Technologies International Corp
NTIC
$77.8M
– –
-166
Closed -$2K
NTLA icon
3929
Intellia Therapeutics
NTLA
$1.57B
– –
-1,879
Closed -$40K
NUGT icon
3930
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.08B
– –
-101
Closed -$12K
NVO
3931
Novo Nordisk
NVO
$203B
– –
-708
Closed -$17K
NWG icon
3932
NatWest
NWG
$75.8B
– –
-1,919
Closed -$15K
NXC
3933
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
– –
-2
Closed –
ADAM
3934
Adamas Trust
ADAM
$856M
– –
-1,594
Closed -$38K
OCFC icon
3935
OceanFirst Financial
OCFC
$1.92B
– –
-7,473
Closed -$200K
IMDX
3936
Insight Molecular Diagnostics
IMDX
$155M
– –
-62
Closed -$3K
OKTA icon
3937
Okta
OKTA
$24.9B
– –
-3
Closed –
OMCL icon
3938
Omnicell
OMCL
$1.64B
– –
-529
Closed -$23K
OPBK icon
3939
OP Bancorp
OPBK
$233M
– –
-445
Closed -$6K
OPK icon
3940
Opko Health
OPK
$985M
– –
-22,604
Closed -$72K
ORC
3941
Orchid Island Capital
ORC
$1.28B
– –
-966
Closed -$36K
ORMP icon
3942
Oramed Pharmaceuticals
ORMP
$179M
– –
-281
Closed -$2K
ORN icon
3943
Orion Group Holdings
ORN
$410M
– –
-11,812
Closed -$78K
OSS icon
3944
One Stop Systems
OSS
$330M
– –
-100
Closed –
OTTR icon
3945
Otter Tail
OTTR
$3.91B
– –
-419
Closed -$18K
OVID icon
3946
Ovid Therapeutics
OVID
$495M
– –
-724
Closed -$5K
OZK icon
3947
Bank OZK
OZK
$5.63B
– –
-10,949
Closed -$529K
PAA icon
3948
Plains All American Pipeline
PAA
$16.6B
– –
-1,200
Closed -$26K
PACB icon
3949
Pacific Biosciences
PACB
$363M
– –
-20,841
Closed -$43K
PAHC icon
3950
Phibro Animal Health
PAHC
$1.44B
– –
-1,516
Closed -$60K
156 157
158
159 160

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.